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Summary
Most of the central circadian clock genes in the mouse exist
as paralog pairs (Per1 and Per2, Cry1 and Cry2, Clock and
Npas2) in which each gene of the pair must be knocked out
to confer arrhythmicity [1–3]. The only exception to this
pattern is Bmal1 (also known as Mop3), the single knockout
of which confers arrhythmicity, despite the presence of its
paralog, Bmal2 (also known as Mop9) [4]. The knockout of
Bmal1 also has significant effects on longevity, metabolism,
etc. [5, 6]. These results have led to the conclusion that
Bmal1 is a singularly essential clock gene and that Bmal2
has a minimal role in the clock system. In contrast, we find
that expression of Bmal2 from a constitutively expressed
promoter can rescue the clock and metabolic phenotypes
of Bmal1-knockout mice, including rhythmic locomotor
activity, rhythmic metabolism, low body weight, and
enhanced fat deposition. Combined with the data of Bunger
and colleagues, who reported that knockout of Bmal1
downregulates Bmal2 [4], we conclude that Bmal1 and
Bmal2 form a circadian paralog pair that is functionally
redundant and that, in the mouse, Bmal2 is regulated by
Bmal1 such that knockout of Bmal1 alone results in a func-
tionally double Bmal1 and Bmal2 knockout. Therefore, the
role(s) ofBmal2may be more important than has been appre-
ciated heretofore.
Results and Discussion
For constitutive expression of Bmal2, we used the promoter
region (2.5 kb) for hEF1a that is expressed in many rodent
tissues, including the suprachiasmatic nuclei (SCN) of the
hypothalamus [7]. The hEF1a promoter was fused to mBmal2
cDNA with five tandem copies of the c-myc tag at the 50 end of
the mBmal2 cDNA (Figure 1A). The construct included the
SV40 intron and polyadenylation site at the 30 end. This
construct is expressed after transient transfection into mouse
3T3 and human HEK293 cells; it is active in transactivation of
E box-containing promoters with both CLOCK and NPAS2
partners (see Figure S1 available online; 2-fold with CLOCK
and 7.4-fold with NPAS2 in 3T3 cells), as we have previously
reported for transactivation of E box-containing promoters
with hBMAL2 (also known as ARNTL2) in heterodimers with*Correspondence: carl.h.johnson@vanderbilt.edu
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construct, and c-myc-tagged BMAL2 was expressed strongly
in spleen, thymus, pancreas, and brain, as well as more
weakly but significantly in liver and lung (Figure 1B). Expres-
sion of c-myc-tagged BMAL2 in mice driven by PhEF1a (B2Tg)
lengthens the behavioral locomotor activity by w0.25 hr as
compared with wild-type (WT) mice (Figure 1C; Figure S2).
Locomotor activity of Bmal1-knockout mice (B1ko) is
arrhythmic; however, PhEF1a-driven expression of BMAL2 in
B1ko mice rescues the rhythmicity (B1koB2Tg; Figure 1C;
Figure S2). In most cases the rescue is apparently complete
(as in B1koB2Tg-1 in Figure 1C; n = 4), whereas in other cases
the rescue is clear but not absolutely complete (as in
B1koB2Tg-2 in Figure 1C; n = 3). There is less total locomotor
activity in the B1ko mouse, but PhEF1a-driven expression of
BMAL2 also partially rescues this loss of activity (Figures
S2D and S2E). Some mice tested in the locomotor activity
assay harbored the PmPer2::mPER2::LUC knockin genetic
construct so that their tissues could also be tested for lumines-
cence rhythms in vitro (see below).
Ectopic expression ofBmal2 also rescues metabolic pheno-
types that are associated with the knockout of Bmal1. For
example, WT mice exhibit circadian rhythms of oxygen
consumption that are disrupted in B1ko mice (Figure 2A;
B1ko mice exhibit either arrhythmicity or ultradian rhythms of
oxygen consumption, Figure S3). Constitutive expression of
Bmal2 in the WT background (B2Tg) does not significantly
affect these metabolic rhythms, but it will rescue robust
rhythmicity in the B1ko background (B1koB2Tg, Figure 2A;
Figure S3). Other metabolic phenotypes that are associated
with the knockout of Bmal1 are significantly (1) reduced
body weight (Figure 2B), (2) enhanced fat index (Figure 2C),
and (3) reduced daily food intake (Figure 2D) in 8-week-old
mice. All three of these metabolic phenotypes exhibited by
B1ko are rescued by the constitutive expression of Bmal2
(B1ko versus B1koB2Tg) but are not affected by Bmal2
expression in the WT background (WT versus B2Tg, Figures
2B–2D).
Therefore, PhEF1a-driven expression of BMAL2 can rescue
circadian and metabolic phenotypes associated with the
knockout of Bmal1 in intact mice. Is this rescue also true for
isolated tissues that can express circadian rhythms in vitro,
as can be assayed by light emission of tissues from mice
with transgenic reporters [10]? Isolated SCN, lung, and liver sli-
ces exhibit circadian rhythms of luminescence in vitro from WT
and B2Tg animals (Figure 3; note that the period is significantly
longer in lung of B2Tg mice). In contrast, isolated tissues—
including the SCN—of neither B1ko nor B1koB2Tg mice
exhibit circadian rhythms in vitro. To be confident that
B1koB2Tg mice in which locomotor activity was rescued cor-
responded exactly with animals whose SCN activity rhythms
in vitro were not rescued, we tested four separate B1koB2Tg
mice (with the PmPer2::mPER2::LUC knockin construct) for
locomotor activity and then sacrificed them for SCN lumines-
cence activity. Figure S4 shows that all four mice exhibited
a rescue of the locomotor activity rhythm, but their SCN
luminescence activity in vitro was not rhythmic. Glucocorti-
coids have been reported to synchronize peripheral clocks
Figure 1. Constitutive Expression of mBmal2
Can Rescue Locomotor Activity Rhythms of the
mBmal1-Knockout Mouse
(A) Structure of the Bmal2-transgene vector
(‘‘5myc-Bmal2’’). The coding region of mBmal2
(cDNA) was fused to an upstream region consist-
ing of five tandem repeats of the c-myc sequence
(5myc) and the human EF-1a promoter and to
a downstream region composed of the SV40
intron-poly(A) sequence [23]. Primers used for
the screening of the transgenic mouse lines are
indicated below the construct as arrows.
(B) The expression of 5myc-BMAL2 in the mouse
with Bmal2 transgene was analyzed by immuno-
blotting with an anti-myc-tag antibody. Lysates
from HEK293 cells with 5myc-Bmal2 transfection
were used as the positive control, and b-actin
was immunoblotted as the loading control.
(C) Locomotor activity records. Representative
activity records (actograms) are shown in the
double-plotted format. Animals were initially in
a 12 hr light:12 hr dark cycle (LD) for at least
10 days and were then transferred to constant
darkness (DD). After at least 20 days in DD, the
mice were re-entrained to LD. Arrows indicate
transitions between different LD cycles. For the
B1koB2Tg mice, four mice showed a complete
behavioral rescue (B1koB2Tg-1 is a representa-
tive example), whereas three mice showed partial rescue (e.g., B1koB2Tg-2). White and black bars at the tops of the actograms indicate the LD cycle
when present. Summary data, including power spectra, period, and activity levels, are depicted in Figure S2.
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317both in vitro and in vivo [11–13]. After treating liver explants
with dexamethasone (DEX, a synthetic glucocorticoid), we
observed persistent circadian rhythms of PER2::LUC lumines-
cence in B1koB2Tg slices, as compared with highly damped
oscillations from B1ko slices (Figure 3). Therefore, even
though expression ofBmal2 is able to rescue behavioral rhyth-
micity and metabolic phenotypes of intact B1ko mice (Figure 1;
Figure 2), it appears to be less effective in rescuing B1ko
phenotypes in isolated tissues (Figure 3).Because the endogenous Bmal2 gene is intact in Bmal1-
knockout mice, why does it not sustain rhythmicity in B1ko
mice in the same way that it does in the B1koB2Tg mice?
A clue to an explanation is found in the original Bmal1-
knockout data [4]; when Bmal1 is knocked out, Bmal2 mRNA
levels are knocked down to basal levels. We repeated these
findings (Figures 4A and 4B). Therefore, it is possible that
Bmal2 expression in WT mice is regulated by BMAL1 so that
knockout of Bmal1 leads to a condition that is essentiallyFigure 2. Expression of Bmal2 Rescues Meta-
bolic Phenotypes of Bmal1-Knockout Mice
(A) Rhythms of oxygen consumption under
2 days of LD 12:12 followed by 3 days of DD
and followed by 1 day of red LL. Each bar is the
mean 6 standard deviation (SD) (n = 4).
(B) Body weight of 8-week-old mice. Each bar
represents the mean 6 SD (n = 8; four males
and four females).
(C) Percentage of body fat composition
measured by nuclear magnetic resonance. Data
are presented as mean 6 SD (n = 8 for each
group).
(D) Daily food intake. Each bar is the mean 6 SD
of eight mice (four male and four female).
(B–D) **p < 0.01, ***p < 0.001. One-way analysis of
variance, post hoc least significant difference
test.
Figure 3. Expression of Bmal2 Does Not Rescue
the Rhythmicity of B1ko Suprachiasmatic Nuclei
or Lung Tissues In Vitro but Can Rescue Liver
Rhythmicity after Dexamethasone Stimulation
(A, C, and E) Raw data of luminescence from
tissues of PmPer2::mPer2-Luc knockin mice moni-
tored in vitro. Tissue explants were dissected on
day 0 and recorded with a LumiCycle apparatus.
The following color codes are used: dark blue,
wild-type (WT); magenta, Bmal2 Tg; black,
Bmal1ko; light blue, Bmal1koBmal2Tg.
(B, D, and F) Period analyses of those data
(AR, arrhythmic), plotted as mean 6 SD (n R 3,
*p < 0.05 by two-tailed t test).
(A and B) Suprachiasmatic nuclei (SCN) slices.
(C and D) Lung slices.
(E and F) Liver slices; + dexamethasone (DEX)
(100 nM) on day 8. In (F), blue histograms
represent the recording interval prior to DEX
treatment (for WT versus B2Tg, p = 0.11) and
red histograms represent the interval during the
DEX treatment.
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318a double Bmal1/Bmal2 knockout and knockdown. Indeed,
examination of the upstream promoter and/or enhancer region
of Bmal2 indicates the presence of eight E boxes (two canon-
ical E boxes [CACGTG] and six noncanonical E boxes [either
CAGCTG or CATGTG]) that could be regulated by BMAL1/
CLOCK and BMAL1/NPAS2 heterodimers [14–16]. To test
this hypothesis, we made a reporter construct with the puta-
tive promoter and/or enhancer region of mBmal2 fused to
luciferase (PBmal2::luc). In transient transfection assays that
introduced this reporter into either mouse 3T3 cells or human
HEK293 cells, we found that BMAL1/NPAS2 or BMAL2/NPAS2
heterodimers could activate Bmal2 expression in both cell
types and that BMAL1/NPAS2 transactivation of PBmal2 could
be inhibited by expression of mCRY2 in HEK293 cells
(Figure 4C; Figure S1E) [14–17]. Additionally, in mouse 3T3
cells, BMAL1/CLOCK and BMAL2/CLOCK heterodimers could
also activate the Bmal2 promoter and/or enhancer region
(Figure 4C).
We conclude that BMAL1 is not absolutely necessary for
circadian rhythms of locomotor activity or metabolic pheno-
types but that it may be replaced functionally by expression
of its paralog BMAL2 from a constitutively expressed
promoter. Combined with the data of Bunger and colleagues,
who reported that knockout of Bmal1 downregulated Bmal2
[4], we conclude that Bmal1 and Bmal2 form a circadian
paralog pair that is functionally redundant, but that in the
mouse, Bmal2 is regulated by Bmal1 such that knockout of
Bmal1 alone results in a functionally double Bmal1 and
Bmal2 knockout. This conclusion is consistent with our obser-
vation that the promoter of mBmal2 is regulated by BMAL1/
NPAS2 and BMAL1/CLOCK transactivation. Some small
interfering RNA (siRNA) analyses have led to the conclusion
that Bmal2 knockdown has no effect on the circadian rhyth-
micity of human osteosarcoma (U2OS) cell cultures [18]. Onthe other hand, other siRNA studies in
3T3 fibroblasts have supported the
opposite conclusion, namely that knock-
ing Bmal2 mRNA levels down disrupts
the circadian system in cell cultures
[19], which is more consistent with the
implications of our study and perhapsindicates that there are tissue- and/or species-specific varia-
tions in the role of Bmal2 in the clock mechanism.
Despite the rescue of behavioral and metabolic phenotypes
by expression of Bmal2 from the hEF1a promoter, constitutive
expression of Bmal2 does not rescue robust and/or sustained
rhythmicity of isolated SCN, liver, or lung tissue in vitro.
Because the SCN is thought to be the central pacemaker
underlying the behavioral locomotor rhythm, it is perplexing
that the B1koB2Tg mice in which the behavioral rhythm is
rescued do not have a concomitant rescue of the in vitro
rhythm of the SCN. This result is not without precedent,
however. For example, another study using Per12/2 mice
found robust circadian rhythms of locomotion, but the lumi-
nescence activity of SCN slices in vitro was essentially
arrhythmic [20]. That report concluded that either (1) a small
population of rhythmic neurons in thePer12/2SCN is sufficient
to drive locomotor rhythms or (2) in vivo physiological factors
can compensate for the atypical activity of Per12/2 SCN. Our
results with B1koB2Tg mice may be another example of this
phenomenon. In summary, our data support a key role for
Bmal2 (Arntl2 in humans) in the clock system that has been
overlooked by previous studies. Bmal2 may be responsible
for many of the important clock and nonclock functions that
have been attributed toBmal1 in the mouse. This is noteworthy
because polymorphisms of Arntl2 in humans may have impor-
tant consequences such as susceptibility to diabetes [21].
Therefore, as we extend our understanding of mammalian
circadian rhythms from the mouse model to humans, it will
be important to appreciate the potential significance of Arntl2.Experimental Procedures
Complete experimental procedures are described in the Supplemental
Experimental Procedures.
Figure 4. The Bmal2 Promoter and Enhancer
Region Is Activated by BMAL1/CLOCK and
BMAL1/NPAS2 Heterodimers
(A and B) Levels of Bmal1 (A) and Bmal2 (B)
mRNA levels in liver. Transcripts of Bmal1 and
Bmal2 were quantified by real-time polymerase
chain reaction and normalized with reference to
Hprt mRNA levels as a control. The data were
normalized by setting the maximum value of
Bmal1 or Bmal2 mRNA levels to 1.0. Blue trian-
gles show data from WT mice, whereas red
squares show data from B1ko mice; lines
connect the averages at each time point (n = 3
or n = 4 except for WT at 56 hr, where n = 2).
(C) Effect of CLOCK/NPAS2 and BMAL1/BMAL2
on expression of the mBmal2 promoter in 3T3
cells. The total amount of plasmid DNA that
was transfected was kept constant by the addi-
tion of empty vector DNA when appropriate.
Data are mean 6 SD (n R 4) of firefly luciferase
activity (PmBmal2::Fluc) normalized by the Renilla
luciferase control (PCMV::Rluc). The activity in
samples transfected with the reporter construct
(i.e., ‘‘PmB2-Fluc’’ without plasmids expressing
other proteins) was set as 1.0. Significant differ-
ences in pairwise comparisons at the p < 0.05
level are indicated by letters.
(D) Control of circadian gene expression by
Bmal1 and Bmal2. Left: in wild-type mice, E box
clock-controlled genes (CCGs) are activated by
both BMAL1 and BMAL2 proteins in combination
with CLOCK and NPAS2. Expression of the
Bmal2 gene is regulated by BMAL1/CLOCK
and/or BMAL1/NPAS2 heterodimers. Right: in
the Bmal1koBmal2Tg mouse, expression of
BMAL2 from the transgene (and possibly from
the endogenous Bmal2 gene that is also acti-
vated by BMAL2 from the transgene) regulates
the expression of the CCGs, thereby rescuing
clock and metabolic phenotypes that result
from Bmal1/Bmal2 knockout and knockdown in
the Bmal1ko mouse.
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To generate a transgenic mouse strain expressing mBmal2 constitutively,
we selected a promoter for elongation factor 1a (PhEF1a) that can drive
constitutive expression in many rodent tissues, including the SCN [7]. PhEF1a
was ligated to five tandem repeats of the c-myc tag (‘‘5myc’’), followed by
the mBmal2 open reading frame ([22]; Figure 1A). Then the SV40 small T
intron and the SV40 early gene transcriptional termination and polyadenyla-
tion signal sequence [23] was fused to the 50 end of the construct. The final
construct is called ‘‘PEF1a-Myc-mB2-SV40intronPA.’’ The transgenic mouse
was made by the Vanderbilt Transgenic Mouse and Embryonic Stem Cell
Shared Resource, and founder mice were screened by polymerase chain
reaction (PCR) for Bmal2 and for the SV40 poly(A) signal. We obtained three
founders of PEF1a-mBmal2 transgenic mice (B2Tg), and all of them were
fertile. Two lines of the B2Tg mice (designated 1 and 3) showed free-running
periods significantly longer than those of wild-type mice in constant
darkness (DD). The other line (2) showed no significant difference in the
free-running period. In this study, we used line 3 to analyze molecular and
physiological circadian rhythms. All the B2Tg mice used in this study were
heterozygous for the PEF1a-Myc-mB2-SV40intronPA transgene.
Promoter and Enhancer Assays
Mouse 3T3 and human HEK293 cells were transfected with Lipofectamine
2000 (Invitrogen) with luminescence reporter constructs PK2.8-Luc
(reporter for the Prokineticin 2 promoter [24]) or pGL4-PmB2 (reporter for
mBmal2 promoter activity) and the pCMV-Rluc as a transfection control.
To make pGL4-PmB2, we amplified a fragment extending from the mouse
Bmal2 upstream region (24706 from transcription start site) to the firstintron (+339 from transcription start site) by PCR from mouse genomic
DNA (C57BL/6 strain) and inserted it into XhoI and BglII sites of the
pGL4.11 luciferase vector (Promega).
Locomotor Behavior Assay
Animal care and use procedures were approved by Vanderbilt University
institutional guidelines. Mice were singly housed in cages equipped with
running wheels on a light:dark (LD) 12:12 cycle for at least 10 days before
being released into constant darkness. ClockLab software (Actimetrics)
was used to collect data and produce double-plotted actograms as well
as the periodogram and activity analyses. c2 periodogram analyses
were performed to obtain periods with the first 20 days of data in DD. To
measure circadian phase angle at the termination of the LD cycle, we fit
linear regressions through the activity onsets for the 7 days before and
6–20 days after release into DD (the first 5 days in DD were excluded to
avoid ‘‘transients’’ [25]).
Oxygen Consumption, Body Weight and Fat Composition, and Food
Intake Assays
Sex- and age-matched mice were used for all metabolic experiments. The
mice were singly housed in indirect calorimetry cages (‘‘OxyMax,’’
Columbus Instruments). Mice were monitored for 2 days in LD, 3 days in
DD, and then 1–2 days in dim red light (red light intensity inside mouse cages
was w1 mmol/m2s), during which time oxygen consumption (VO2) was
measured every 15 min. Energy expenditure was calculated as described
previously [26]. LumiCycle software (Actimetrics) was used to subtract the
24 hr moving average from the raw VO2 results for the 3 days in DD and to
Current Biology Vol 20 No 4
320smooth the data by 2 hr adjacent averaging. The period of the VO2 rhythm in
DD was determined by periodogram analyses of the smoothed data. Body
fat composition was determined with an mq10 nuclear magnetic resonance
analyzer (Bruker Optics). For food intake assessment, mice were placed in
individual cages and the amount of food that was consumed in 24 hr was
measured.
Tissue Culture and In Vitro Luminescence Recording
PmPer2::mPER2::LUC knockin mice (a gift from J. Takahashi) that had been
backcrossed with the C57BL/6 strain for more than ten generations were
crossed with Bmal1+/2 and Bmal2 transgenic (B2Tg) mice. All B2Tg or
PmPer2::mPER2::LUC mice used in this study were heterozygous. One to
two hours before lights off of LD 12:12, the mouse was sacrificed by cervical
dislocation under dim red light, and cultures of SCN, liver, and lung were
prepared as previously described [27]. In vitro rhythms were analyzed for
period, etc. with the analysis software for the LumiCycle (Actimetrics,
version 2.31) [27].
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cub.2009.12.034.
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